Impact Factor Journals

LACEY, M., L. BÉRESOVÁ, A. SROVNALOVÁ, P. POLISHCHUK, M. SALA, Z. ŠKROTT, M. HAJDÚCH, P. DŽUBÁK, J. BÁRTEK, A. ŠIŠKOVÁ, M. LÖFFELMANN, R. NENCKA, M. MISTRÍK
Autophagy revealed as a targetable vulnerability in senescent cells by cell painting phenotypic profiling: a mechanistic study of MCOPPB and related compounds. Geroscience. 2026, ISSN: 2509-2723, PMID: 42062708,  PDF.
GIEBELHAUS, R., M. HEROLD, J. HARYNUK, D. ALONSO, B. AMER, C. BROECKLING, P. CHARISIADIS, R. CUMERAS, A. DE LA MATA, W. DUNN, F. FRANCHINA, H. GIKA, J. KIRWAN, I. MUTI, L. NAJDEKR, E. PUJOS-GUILLOT, P. STEFANUTO, T. STEININGER-MAIRINGER, A. THAKKER, O. FIEHN
Best Practices in GC-MS and GC × GC-MS-Based Metabolomics and Volatile Analyses: An International Survey. Analytical Chemistry. 2026, ISSN: 0003-2700, PMID: 42030522,  PDF.
PERLA, S., C. ALLADI, M. LIU, S. MISRA, S. SIRINIVASAMURTHY, V. SAMARA, S. NAIR, S. JAIN
Epigenetic Regulation in Hypertension: Mechanistic Insights and Environmental Influences. American Journal of Hypertension. 2026, ISSN: 0895-7061, PMID: 42001208,  PDF.
CAPRIELLO, I., A. DÖMLING
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. ACS Pharmacology & Translational Science. 2026, 9(4), 764-770, ISSN: 2575-9108, PMID: 41988370,  PDF.
DENZLER, A., D. SRIRAMULU, J. PECHA, P. POLISHCHUK
CReM-pharm: de novo 3D pharmacophore-based design with synthetic accessibility awareness. Journal of Cheminformatics. 2026, ISSN: 1758-2946, PMID: 41987310,  PDF.
VAN DER STRAAT, R., R. OERLEMANS, Y. CONG, J. BOXMA, R. BULAI, C. RIO-BERGE, L. KOEKEMOER, T. ZARGANES-TZITZIKAS, M. GUAN, P. MARPLES, F. REGGIORI, M. GROVES, A. DÖMLING
Ugi-Tetrazole-Derived α‑Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV‑2 3CLpro. ACS Medicinal Chemistry Letters. 2026, 17(4), 856-865, ISSN: 1948-5875, PMID: 41982734,  PDF.
VAN DER STRAAT, R., J. KALINOWSKA-TLUSCIK, K. KURPIEWSKA, A. DÖMLING
Systematic Expansion of an Ugi-Based Multicomponent Synthesis of Tetrasubstituted Imidazoles. ACS Omega. 2026, 11(13), 20889-20894, ISSN: 2470-1343, PMID: 41970876,  PDF.
CHEN, S., M. CAL, Q. MONDILE, R. OERLEMANS, M. MUKIM, A. DÖMLING, O. BISHOP, P. MASER, M. GROVES
Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi. ChemMedChem. 2026, 21(6), e202500817, ISSN: 1860-7179, PMID: 41886248,  PDF.
DAS, V., M. HAJDÚCH
Oncology drug repurposing as a blueprint for Alzheimer's therapy. Alzheimer's & dementia. 2026, 12(1), e70231, ISSN: 2352-8737, PMID: 41816361,  PDF.
RAMMAH, M., A. REYES ROMERO, N. HALABI, S. ABUAQUEL, A. GUENNOUN, A. DÖMLING, J. SHAN, L. CHOUCHANE
A small‑molecule HDAC/PDE modulator activates human adipocyte UCP1 and resolves inflammatory signaling. Journal of Translational Medicine. 2026, ISSN: 1479-5876, PMID: 41787480,  PDF.